IPO Archives

News and Trends 10 Mar 2025

23andMe: the collapse of a genomics giant

23andMe was once worth $6 billion and is now a penny stock. Layoffs, data breaches, and mass resignations plagued the genomics giant. How did it all unfold?

March 10, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 10 Oct 2024

Second biotech IPO boom of the year: what does it mean for the industry?

Discover why biotech is experiencing a second IPO boom in 2024 and what it means for the broader industry.

October 10, 2024 - 9 minutesmins - By Monica Karpinski

In Depth 26 Jun 2024

Biotech megadeals: Exploring the surge in $100M+ deals

Biotech and healtcare contributed to more than one out of three megadeals in 2024, find out the reasons behind it.

June 26, 2024 - 9 minutesmins - By Jules Adam

alchemyrefiner alchemymagic 3 04e4a427 d1fa 4258 9dab 2690330368fd 0

Podcast 19 Apr 2024

The biotech investment landscape in 2024

Dive into 2024’s biotech investment strategies with RTW Investments on our podcast. Discover trends shaping the landscape ahead.”

April 19, 2024

In Depth 8 Apr 2024

A wave of biotech layoffs: will the trend continue throughout 2024?

Thousands of jobs have been at risk over the past year due to mass layoffs by biotech companies across the globe.

April 8, 2024 - 9 minutesmins - By Willow Shah-Neville

In Depth 18 Mar 2024

Will the US biotech funding surge trigger a renaissance in the global biotech industry?

After a couple of challenging years in biotech investment, the US leads the march for recovery. Delve into the specifics driving this uptick.

March 18, 2024 - 10 minutesmins - By Jules Adam

News and Trends 8 Jan 2024

Is the biotech industry poised for recovery in 2024?

The past few years have been challenging for the industry but 2024 might be the year marking the biotech recovery.

January 8, 2024 - 5 minutesmins - By Jules Adam

In Depth 11 Sep 2023

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

With biotech funding trends always evolving, HSBC Innovation Banking’s inaugural Venture Healthcare Report lays out the trends seen in the first half (1H) of 2023, where valuations underwent a necessary reset, and venture capitalists emerged from their cautious stance, eventually embarking on a fresh wave of investments. However, an overall decline in investment was still […]

September 11, 2023 - 5 minutesmins - By Willow Shah-Neville

Gene therapy genenta science genflow biosciences

News and Trends 21 Jan 2022

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

After a drought of more than a year, the European gene therapy sector saw initial public offerings from Genenta Science and Genflow Biosciences. The firms aim to shine as biotech stocks elsewhere perform poorly. Until recently, European gene therapy companies were going through a dry spell in terms of launching initial public offerings (IPO). The […]

January 21, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 10 Nov 2021

Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks

German life sciences heavyweight Evotec raised around €376M ($435M) in its US debut on the Nasdaq last week, fueling tentative hopes of renewed investor interest in biotech stocks after a rollercoaster year. The company downsized its initial IPO target of around €500M ($576M) by offering fewer shares than initially planned. This is widely seen as […]

November 10, 2021 - 4 minutesmins - By Victor Kotsev

oxford nanopore technologies genomics sequencing

News and Trends 15 Oct 2021

Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO

Oxford Nanopore Technologies, until recently one of very few unicorns in the European biotech industry, had a stellar IPO on the London Stock Exchange late last month. This is ushering in a whole new generation of DNA sequencing, genetics research, and diagnostics. During the first day of the IPO, which bagged the firm over €400M […]

October 15, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 7 Oct 2021

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery

Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts to use artificial intelligence to fuel drug discovery, with global tech investors often taking the lead. The Oxford, UK-based company Exscientia has one of the most mature artificial intelligence (AI)-focused drug discovery pipelines, alongside companies like BenevolentAI in the UK, […]

October 7, 2021 - 5 minutesmins - By Mark Zipkin

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

IPO

23andMe: the collapse of a genomics giant

Second biotech IPO boom of the year: what does it mean for the industry?

Biotech megadeals: Exploring the surge in $100M+ deals

The biotech investment landscape in 2024

A wave of biotech layoffs: will the trend continue throughout 2024?

Will the US biotech funding surge trigger a renaissance in the global biotech industry?

Is the biotech industry poised for recovery in 2024?

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks

Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!